Income statement revenue $464.11M (-2.6% YoY).Operating income $34.53M (-41.8% YoY).Pre-tax result $23.29M (-48.9% YoY).Net result $23.61M (-36.2% YoY).

Cardiac Rhythm Management Neuromodulation: $173.71M (+1.0% YoY)
Cardio And Vascular: $280.31M (-2.3% YoY)
Other Markets: $10.09M (-42.8% YoY)
Selling, general and administrative: $57.7M (+9.0% YoY)
Research, development and engineering: $11.28M (-20.8% YoY)
Restructuring and other charges: $9.44M (+256.0% YoY)
Other expense: $11.24M (-18.2% YoY)
Income tax benefit: $314K

Loading financials

Income statement income statement flow. Revenue $464.11M. Net result $23.61M.

Income statement revenue $464.11M (-2.6% YoY).Operating income $34.53M (-41.8% YoY).Pre-tax result $23.29M (-48.9% YoY).Net result $23.61M (-36.2% YoY).

Cardiac Rhythm Management Neuromodulation: $173.71M (+1.0% YoY)
Cardio And Vascular: $280.31M (-2.3% YoY)
Other Markets: $10.09M (-42.8% YoY)
Selling, general and administrative: $57.7M (+9.0% YoY)
Research, development and engineering: $11.28M (-20.8% YoY)
Restructuring and other charges: $9.44M (+256.0% YoY)
Other expense: $11.24M (-18.2% YoY)
Income tax benefit: $314K